首页 | 本学科首页   官方微博 | 高级检索  
     

CCR9和CCL25蛋白在上皮性卵巢癌中表达及临床意义
引用本文:马水根 杨进 廖革望 史彩霞 金志红 眭鸿颖 陶光实. CCR9和CCL25蛋白在上皮性卵巢癌中表达及临床意义[J]. 现代生物医学进展, 2015, 15(4): 727-730
作者姓名:马水根 杨进 廖革望 史彩霞 金志红 眭鸿颖 陶光实
作者单位:中南大学湘雅医学院附属肿瘤医院;湖南中医药大学第一附属医院;中南大学湘雅二医院
基金项目:湖南省自然科学基金项目(14JJ7060)
摘    要:目的:探讨CCR9和CCL25蛋白在不同卵巢组织中的表达及其与上皮性卵巢癌患者临床病理因素之间的关系。方法:通过组织芯片结合免疫组织化学法检测78例上皮性卵巢癌组织和30例正常卵巢组织中CCR9和CCL25表达水平,结合上皮性卵巢癌病人的临床病理资料,进行统计分析。结果:CCR9和CCL25在上皮性卵巢癌中高表达,在正常卵巢组织中低表达,二者的表达与上皮性卵巢癌的组织类型、患者年龄无显著相关(P0.05),而与淋巴结转移、组织学分级和临床分期有显著相关(P0.05);上皮性卵巢癌组织中CCR9与CCL25表达相关(P0.05)。结论:CCR9和CCL25在上皮性卵巢癌的发生发展中可能起重要作用,二者可能是上皮性卵巢癌治疗的一个潜在的分子靶点。

关 键 词:CCR9  CCL25  上皮性卵巢癌  组织芯片  免疫组化

Expressions of CCR9 and CCL25 in Epithelial Ovarian Carcinomaand Clinic Significance
MA Shui-gen;YANG Jin;LIAO Ge-wang;SHI Cai-xia;JIN Zhi-hong;SUI Hong-ying;TAO Guang-shi. Expressions of CCR9 and CCL25 in Epithelial Ovarian Carcinomaand Clinic Significance[J]. Progress in Modern Biomedicine, 2015, 15(4): 727-730
Authors:MA Shui-gen  YANG Jin  LIAO Ge-wang  SHI Cai-xia  JIN Zhi-hong  SUI Hong-ying  TAO Guang-shi
Affiliation:MA Shui-gen;YANG Jin;LIAO Ge-wang;SHI Cai-xia;JIN Zhi-hong;SUI Hong-ying;TAO Guang-shi;Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University;The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine;The Second Xiangya Hospital of the Central South University;
Abstract:Objective:To investigate the expressions of CCR9 and CCL25 protein in different ovarian tissues and the relationshipbetween their expression and clinical pathological factors of epithelial ovarian cancer patients.Methods:Tissue microarray and immunohistochemistrywere used to detect the expressions of CCR9 and CCL25 in 78 cases of epithelial ovarian cancer and 30 cases of normalovarian tissues. The relationship between their expression and clinical pathological factors of epithelial ovarian cancer patients was statisticallyanalyzed.Results:The expressions of CCR9 and CCL25 in epithelial ovarian cancer was high, but in normal ovarian tissue theirexpression was low. The expressions of CCR9 and CCL25 did not correlate with histological type and age of patients (P>0.05), whilethere was a positive correlation between the expressions of CCR9 and CCL25 with lymphnode metastasis, histological grade and clinicalstage(P<0.05). The expression of CCR9 was associated with that of CCL25(P<0.05).Conclusion:CCR9 and CCL25 may play an importantrole in the development of epithelial ovarian cancer, which may be a potential molecular target for the treatment of epithelial ovariancancer.
Keywords:CCR9  CCL25  Epithelial ovarian cancer  Tissue microarray  Immunohistochemistry
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号